Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Aclarion Inc. ACON

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine.


Recent & Breaking News (NDAQ:ACON)

    John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor

    Accesswire 2 days ago

    Nociscan Selected for Inclusion in Pivotal National Institutes of Health (NIH) Study for Low Back Pain

    Accesswire September 19, 2022

    Aclarion, Inc. to Present at Investor Summit Group's Q3 Virtual Conference

    Newsfile August 4, 2022

    Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan

    Accesswire July 20, 2022

    Aclarion to Present 2-year Follow Up Data on Pivotal Clinical Trial Linking Nociscan to Better Surgical Outcomes for Discogenic Low Back Pain

    Accesswire June 22, 2022

    Aclarion, Inc. Announces Closing of $9.4 Million Initial Public Offering

    Accesswire April 26, 2022

    Aclarion, Inc. Announces Listing on Nasdaq and Pricing of $9.4 Million Initial Public Offering

    Accesswire April 21, 2022